PHRX (Pharmagen) Total Current Assets: $0.84 Mil (As of Mar. 2014)


What is Pharmagen Total Current Assets?

Pharmagen PHRX -90.00% Total Current Assets is $0.84 Mil as of Mar. 2014.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Pharmagen's total current assets for the quarter that ended in Mar. 2014 was $0.84 Mil.

Pharmagen  (OTCPK:PHRX) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Pharmagen's Liquidation Value for the quarter that ended in Mar. 2014 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.265-9.309+0.75 * 0.326+0.5 * 0.17
=-8.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen Total Current Assets Related Terms

Pharmagen Total Current Assets Historical Data

* Premium members only.

The historical data trend for Pharmagen's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen Total Current Assets Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
Total Current Assets
0.01 0.04 1.59 0.88

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.17 1.36 1.43 0.88 0.84

Pharmagen Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Pharmagen's Total Current Assets for the fiscal year that ended in Dec. 2013 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=0.226+0.368+0.137+0.148
=0.88

Pharmagen's Total Current Assets for the quarter that ended in Mar. 2014 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=0.265+0.326+0.17+0.076
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $0.84 Mil mean?
Pharmagen (PHRX) has a Total Current Assets of $0.84 Mil as of Mar. 2014. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Pharmagen and its competitors.
Is Pharmagen's Total Current Assets too high?
Pharmagen's current Total Current Assets is $0.84 Mil.
How does Pharmagen's Total Current Assets compare to FZMD and SNYR?
Pharmagen's Total Current Assets of $0.84 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Medical Distribution company?
A good Total Current Assets depends on the Medical Distribution industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Pharmagen and its competitors. Pharmagen's current Total Current Assets is $0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current Total Current Assets of $0.84 Mil. The current Total Current Assets is $0.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Pharmagen (PHRX), the current Total Current Assets is $0.84 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.